Table 1.
Pathology | Animal/Cell Line Model | Arginase Levels | Proposed Trigger Signal | Proposed Disease Mechanism | Ref. |
---|---|---|---|---|---|
Diabetes-induced vasculo-pathy | Bovine aortic endothelial cells exposed to glucose or activated for Arg1 upregulation by adenoviral delivery; Arg1-deficient mouse model | ↑ Arg1 | Glucose treatment activates Rho-associated protein kinases, which induce macrophages to upregulate Arg1 | Substrate depletion by Arg1 reduces NO• and leads to impaired vascular relaxation, increased blood flow, and upsurge of reactive oxygen species, which causes premature endothelial cell senescence and defective vascular repair | [58] |
Diabetic mouse model; blood samples from diabetic patients | Increased plasma glucose levels induce the release of Arg1 via serum exosomes | [59] | |||
Mice induced to diabetes by streptozotocin; bovine retinal endothelial cells | High glucose levels activate NOX2 leading to upregulated Arg1 | [60] | |||
Obesity-induced vasculo-pathy | Diet-induced obesity and metabolic syndrome mouse model | ↑ Arg1 | High-fat, high-sucrose treatment activates Rho-associated protein kinases, which increases Arg1 expression | Upregulated synthesis of polyamines by Arg1 promotes cell proliferation and fibrosis; increased levels of reactive oxygen species contribute to dysfunction | [61] |
Arterial thickening, fibrosis, and stiffening | Arg1-deficient mouse model; rat aortic smooth muscle cells | ↑ Arg1 | Angiotensin II acts upon the renin–angiotensin system and induces arginase upregulation | Enhanced synthesis of polyamines/proline leads to vascular cell proliferation and collagen formation, which changes smooth muscle tone | [62] |
Hyper-tension | Obese and lean male rat models | ↑ Arginase1 | Obesity-induced arginase upregulation | L-Arginine depletion reduces NO•-mediated arterial vasodilation | [63] |
Arterio-genesis | Male mice submitted to peripheral arteriogenesis; mouse primary artery endothelial cells and smooth muscle cells | ↑ Arg1 | Shear stress induces monocytes maturation to macrophages, which impairs M1/M2 to favor Arg1 expression | Enhanced Arg1 activity promotes perivascular M2 macrophage accumulation, which contributes to cell proliferation | [64] |
Myocardial infarction | Male mouse submitted to surgical ligation of the left anterior descending coronary artery to induce myocardial infarction | ↑ Arg1 | Neutrophils are recruited and infiltrate into the infarcted area, activating the macrophages to favor Arg1 expression | Increased Arg1 activity results in enhanced proline and collagen synthesis, leading to fibrosis, ventricular remodeling, and eventual heart failure | [65] |
Erectile dysfunction | Patients with a medical diagnosis of erectile dysfunction | ↑ Arg1 and Arg2 | Genetic polymorphisms induce Arg1 and Arg2 expression and activity | L-Arginine depletion leads to endothelial dysfunction and impaired smooth muscle relaxation; erectile dysfunction is an early sign of cardiovascular diseases | [66] |
Chronic obstructive pulmonary disease | Ex vivo pulmonary vascular tissue from smokers | ↑ Arg1 | Tobacco smoking upregulates the arginase pathway | Imbalance of polyamines/NO• causes vascular remodeling, airway dysfunction, and oxidative stress | [67] |
Pulmonary hypertension | Human pulmonary artery smooth muscle cell | ↑ Arg2 | Induced hypoxia activates protein kinases and transcription factors leading to the upregulation of Arg2 expression | Increased synthesis of polyamines leads to vascular smooth muscle cell proliferation and remodeling; decreased NO• synthesis impairs vasodilation, which contributes to dysfunction and pulmonary hypertension | [68] |
Human pulmonary artery smooth muscle cell; male mice exposed to hypoxia | [69] | ||||
Pulmonary fibrosis | Male mice with bleomycin-induced pulmonary fibrosis | ↑ Arg2 | Pro-inflammatory T helper cells change M1/M2 polarization and increase Arg2 expression | Increased biosynthesis of polyamines and collagen activates lung fibroblast proliferation and differentiation | [70] |
Primary bronchial cultures from cystic fibrosis patients | ↑ Arginase1 | F508del gene mutation leads to excessive arginase activity in the pulmonary tissue | Increased arginase expression results in a build-up of fibrotic mass; a decrease of NO• levels induces the deregulation of epithelial fluid transport in the lungs and reduce cilia motility | [71] | |
Cystic fibrosis pediatric patients | High levels of arginase promote collagen deposition and NOS uncoupling, causing oxidative stress and tissue damage | [72] | |||
Cystic fibrosis patients | ↑ Arg1 | Recessive gene mutation leads to an excessive arginase activity in pulmonary tissue | Reduced NO• impairs smooth muscle relaxation, bronchodilation, and bacterial killing mechanisms | [73] | |
Asthma | Asthmatic patients | ↑ Arg1 | Allergen activation of IgE leads to neutrophil infiltration in lungs and activation of M2 arginase-expressing macrophages | Upregulation of Arg1 increases mucus production and smooth muscle contraction. Arg1 seems to correlate to bronchial asthma | [74] |
↑ Arg2 | Chronic airway inflammations have high co-expression of Arg2 and iNOS | Arg2 delivers L-ornithine into mitochondria, providing nitrogen to an autonomous L-arginine-NO•-citrulline cycle and sustaining high NO• levels, which seems related to more severe and reactive conditions | [75] | ||
Human bronchial epithelial cell line (BET1A); Arg2-deficient mice with allergen-induced asthma | ↑ Arg2 | Allergens enhance hypoxia-induced factors, which activate IL-13 to upregulate Arg2 | Increased Arg2 is suggested to be a counter-regulatory mechanism to reduce signal transduction and suppress airway inflammation | [76] | |
Mite-challenged NC/Nga mouse model of asthma | ↑ Arg1 | Allergen activation induces the expression of arginase-upregulating mechanisms | Arginase decreases NO• levels, suppressing anti-inflammatory, bronchodilatory, and vascular modulating effects | [77] | |
Chronic rhino-sinusitis | Fragments of mucosa collected from the ethmoid sinus of chronic rhinosinusitis patients | ↑ Arg2 | Several cytokines found in the sinus mucosa lead to enhanced arginase expression | Increased Arg2 leads to cell and collagen proliferation and decreases NO• levels, which suppresses bronchodilatory and anti-inflammatory effects | [78] |
Tuberculosis | Tissue samples from active tuberculosis patients; mouse model infected with Mycobacterium tuberculosis | ↑ Arg1 | Intracellular parasites circumvent NO• toxicity through the induction of Arg1-expressing macrophages in lungs | High Arg1 expression leads to collagen deposition and lung damage, which drives to inflammation by inhibiting type 1 helper T cells | [79] |
Inflammatory bowel disease | Mouse model of inflammatory bowel disease by dextran sulfate sodium induction | ↓ Arg1 | Extracellular matrix protein 1 (ECM1) in macrophages impairs M1/M2 polarization decreasing the expression of Arg1 | Reduction of Arg1 suppresses tissue repair mechanisms and, together with upregulated expression of inflammatory cytokines, increases chronic inflammatory response | [80] |
Autoimmune (type 1) diabetes | Diabetic female mouse model induced by hyperglycemia | ↑ Arg1 | Increased plasma glucose levels impair M1/M2 polarization | Decreased NO• levels lead to a pro-inflammatory effect, weakening innate immunity | [81] |
Arthritis | Synovial tissue samples from rheumatoid arthritis patients; arthritis mouse model (K/BxN) | ↓ Arg1 | Transcription factor Fos-related antigen 1 downregulate Arg1 expression by binding to the promoter region | Reduction of Arg1 suppresses polyamines synthesis and subsequently downregulates tissue repair mechanisms and counter-regulates pro-inflammatory cytokines | [82] |
Multiple sclerosis | Arg2-knockout mice with induced autoimmune encephalomyelitis | ↑ Arg2 | Impaired M1/M2 macrophage polarization | Upregulated Arg2 stimulates the production of T helper 17 cells-differentiating cytokines, which induces inflammation | [83] |
Viral infection | Patients with severe fever and thrombocytopenia syndrome | ↑ Arg1 | Viral-induced impairment of M1/M2 polarization favors the upregulation of Arg1 | Arg1 causes L-arginine deficiency, which is associated with decreased NO• and suppresses antiviral immunity | [84] |
Mice infected with Trypanosoma cruzi and Schistosoma mansoni | [85] | ||||
Peripheral lymph node cells from HIV patients | [86] | ||||
Peritonitis | Murine macrophage-like cell line (RAW264.7) and human monocyte cell line (THP-1) | ↑ Arg1 | IL-4-stimulated inflammation upregulates cytochrome P450 1A1, which impairs M1/M2 polarization | Increased Arg1 expression is associated with compensatory response mechanisms against an uncontrolled inflammation | [87] |
Acute myeloid leukemia | Human acute myeloid leukemia cell lines (THP-1, U937, MOLM16, K562) | ↑ Arg2 | Increased acute myeloid leukemia blast cells overexpressing Arg2 | Arg2 activity reduces IFN-γ and inhibits T cell immune-suppressive response | [88] |
Chronic myelo-monocytic leukemia | Human bone marrow mononuclear cells | ↑ Arg1 | Mutations in epigenetic regulators upregulate Arg1 | L-Arginine depletion by Arg1 suppress T-cells and contributes to immune evasion | [89] |
Basal-like breast cancer | Human mammary epithelial cells (HeLa, HMEC, HMEC-ras, MDA-MB-231, MDA-MB-468) | ↑ Arg2 | Oncogene transformations trigger Arg2 expression | Arg2 upregulated between DNA synthesis and mitotic phases of cancer cells cycle promotes cell proliferation | [90] |
Neuro-blastoma | Neural crest cell line (R1113T); neuroblastoma cell lines (SKNAS, KELLY, LAN-1, IMR-32,); Ewing’s sarcoma cell line (SKNMC); sympathetic ganglion-derived stem cells (SZ16) | ↑ Arg2 | IL-1β and TNF-α established a feedback loop to upregulate Arg2 expression via p38 and extracellular regulated kinases signaling | Arg2 induces cell proliferation and an immunosuppressive microenvironment due to inhibition of T cell cytotoxicity | [91] |
Pancreatic ductal adeno-carcinoma | Human pancreatic ductal adenocarcinoma cell lines (AsPC-1, HPAC, MIA PaCa-2, PANC-1, SUIT-2, PA-TU-8988T); Arg2-deficient mouse pancreatic ductal adenocarcinoma cell lines | ↑ Arg2 | Arg2 is increased upon obesity and as a result of activating oncogenic mutations | Tumors (but not cultured cancer cells lacking the in vivo tumor microenvironment) need arginase to dispose of the excess of nitrogen accumulated to enhance tumorigenicity | [92] |
Melanoma | Patient with metastatic L-arginine auxotrophic melanoma | ↑ Arg2 | Defects in the expression of OTC and ASS enzymes result in a dependence of extracellular L-arginine; counter-regulatory mechanisms lead to the upregulation of Arg2 | Tumor cells were shown to be auxotrophic and avid for L-arginine to keep cell proliferation; high expression of Arg2 is induced to increase catalytic efficiency | [93] |
Human melanoma cell lines from patients with melanoma metastasis adhered to confluent human umbilical vein endothelial cells layers | Pro-inflammatory T helper cells change M1/M2 polarization and increase Arg2 expression | Arg2 enhances melanoma cell proliferation through polyamine production and promotes metastasis through enhancing H2O2 production and STAT3 signaling | [94] | ||
Ovarian carcinoma | Human ovarian cancer cell lines (OVP-10, AD-10, A2780, Skov3, CaOv-3, MDAH2774, OvCa-14) | ↑ Arg1 | Tumor-derived exosomes containing Arg1 are released into circulation | Increased Arg1 expression inhibits antigen-specific T-cell proliferation and is related to a worse prognosis | [95] |
Osteosarcoma | Human osteosarcoma cell lines (SaOS-2 and OS-17) | ↑ Arg2 | Hypoxic environment upregulates Arg2 | Arg2 induces immunosuppression by inhibition of T-cells function | [96] |
Glioma | Mouse glioma cell lines (GL261, KR158B) | ↑ Arg1 | Myeloid-derived suppressor cells overexpressing Arg1 infiltrate into the tumor | Increased Arg1 expression suppresses the efficacy of the immune system | [97] |
Hepato-cellular carcinoma | Human hepatocellular carcinoma cell line (Huh7) | ↑ Arg1 | Impaired M1/M2 polarization induces Arg1 upregulation | Overexpression of Arg1 promotes cell proliferation, migration, and invasion, being a critical process in cancer metastasis and progression | [98] |
Patients with advanced hepatocellular carcinoma | Deprivation of L-arginine recycling enzymes OTC and ASS at the transcription or translational level | Tumor auxotrophic for L-arginine to enable cell proliferation and viability; L-arginine deprivation therapy can be a therapeutic approach | [99] | ||
Cervical cancer | Human squamous cell carcinoma cells from patients | ↑ Arginase1 | Increased levels of circulating IL-10 and decreased levels of IFN-γ enhance arginase activity | Upregulated arginase levels contribute to the tumor immunosuppressive microenvironment | [100] |
Alzheimer | Alzheimer’s disease mouse models | ↑ Arg1 and Arg2 | Microglial activation results in cytokines production, which induces the expression of arginase in brain | Arginase overexpression at β-amyloid deposition sites leads to NOS uncoupling, O2•− generation, and neuro-degenerative oxidative stress | [101] |
Acute traumatic brain injury | Male rats submitted to traumatic brain injury surgery | ↑ Arg1 | Elevation of pro-inflammatory cytokines induces Arg1 expression | Increased Arg1 leads to eNOS uncoupling and enhances oxidative stress, inflammation, and vascular dysfunction | [102] |
Fronto-temporal dementia | Male transgenic mice expressing a mutant form of human microtubule-associated protein tau | ↑ Arginase1 | Mutations in microtubule-associated protein tau | Functional significance of arginase remains uncertain as the production of polyamines enhances microtubule stability, which should reduce inflammation and tau proteins | [103] |
Neuro-degeneration and neuro-vascular permeability | Male mice treated with homocysteine to induce vascular dysfunction and stroke-like symptoms | ↓ Arginase1 | Elevated levels of homocysteine, produced from methionine, lead to hyperhomocysteinemia, impairing NOS pathway | Upregulated NO• levels lead to nitrosative stress, extracellular matrix degradation, blood–brain barrier permeability, and neurodegeneration | [104] |
Huntington’s disease | Post-mortem brain sections from patients with Huntington’s disease | ↑ Arg1 | Metabolic impairment of the urea cycle in the brain | Increased urea in the brain induces neurodegeneration by impaired osmoregulation | [105] |
Acute ischemic stroke | Peripheral blood samples from patients with a first-ever acute ischemic stroke | ↑ Arg1 | Stroke induces the downregulation of a microRNA, which upregulates the Arg1 expression | Increased Arg1 acts against the activation of pro-inflammatory signals after stroke but may also be implicated in stroke-induced immunosuppression | [106] |
Cerebral ischemia and excitotoxicity | Arg2-knockout mice with permanent distal middle cerebral artery occlusion or induced excitotoxicity | ↓ Arg2 | Arg2 deficiency worsens brain injury after an ischemic event | Arg2 may play a substantial protective role by regulating NO• levels and controlling reactive species | [107] |
↑ increased levels; ↓ decreased levels; 1 unspecified arginase isoform.